These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 25141246

  • 1. Risk of upper gastrointestinal ulcers in patients with osteoarthritis receiving single-tablet ibuprofen/famotidine versus ibuprofen alone: pooled efficacy and safety analyses of two randomized, double-blind, comparison trials.
    Bello AE, Kent JD, Grahn AY, Rice P, Holt RJ.
    Postgrad Med; 2014 Jul; 126(4):82-91. PubMed ID: 25141246
    [Abstract] [Full Text] [Related]

  • 2. Gastroprotective efficacy and safety of single-tablet ibuprofen/famotidine vs ibuprofen in older persons.
    Bello AE, Kent JD, Holt RJ.
    Phys Sportsmed; 2015 Jul; 43(3):193-9. PubMed ID: 26165391
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Budget impact modeling for a single-tablet formulation of ibuprofen and famotidine for prevention of upper gastrointestinal ulcers in patients with osteoarthritis and/or rheumatoid arthritis.
    Kuan R, Holt RJ, Johnson KE, Kent JD, Peura DA, Malone D.
    Clin Ther; 2013 Mar; 35(3):321-32. PubMed ID: 23497762
    [Abstract] [Full Text] [Related]

  • 5. A fixed-dose combination ibuprofen and famotidine (Duexis).
    Med Lett Drugs Ther; 2011 Oct 31; 53(1376):85-6. PubMed ID: 22033211
    [Abstract] [Full Text] [Related]

  • 6. Double-blind randomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers.
    Laine L, Kivitz AJ, Bello AE, Grahn AY, Schiff MH, Taha AS.
    Am J Gastroenterol; 2012 Mar 31; 107(3):379-86. PubMed ID: 22186979
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. One-year open-label safety evaluation of the fixed combination of ibuprofen and famotidine with a prospective analysis of dyspepsia.
    Bello AE, Kent JD, Grahn AY, Ball J, Holt RJ.
    Curr Med Res Opin; 2015 Mar 31; 31(3):397-405. PubMed ID: 25495134
    [Abstract] [Full Text] [Related]

  • 11. HZT-501 (DUEXIS(®); ibuprofen 800 mg/famotidine 26.6 mg) gastrointestinal protection in the treatment of the signs and symptoms of rheumatoid arthritis and osteoarthritis.
    Schiff M, Peura D.
    Expert Rev Gastroenterol Hepatol; 2012 Feb 31; 6(1):25-35. PubMed ID: 22149579
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A fixed dose combination of ibuprofen and famotidine.
    Birk JW, Myers M.
    Expert Opin Investig Drugs; 2009 Sep 31; 18(9):1385-91. PubMed ID: 19659445
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL, Aisenberg J, Lanza F, Schwartz H, Sands GH, Berger MF, Pan S.
    Clin Ther; 2006 Mar 31; 28(3):340-51. PubMed ID: 16750449
    [Abstract] [Full Text] [Related]

  • 16. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
    Goldstein JL, Cryer B, Amer F, Hunt B.
    Clin Gastroenterol Hepatol; 2007 Oct 31; 5(10):1167-74. PubMed ID: 17916545
    [Abstract] [Full Text] [Related]

  • 17. [Prevention of NSAID induced gastroduodenal ulcers].
    Hansen JM, Bytzer P.
    Ugeskr Laeger; 2001 Oct 29; 163(44):6103-5. PubMed ID: 11715151
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Editorial: single-tablet ibuprofen/double-dose famotidine for reduction of gastric and duodenal ulcers (REDUCE Trials): what can be reduced?
    Chan FK.
    Am J Gastroenterol; 2012 Mar 29; 107(3):387-8. PubMed ID: 22388022
    [Abstract] [Full Text] [Related]

  • 20. A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.
    Cryer BL, Sostek MB, Fort JG, Svensson O, Hwang C, Hochberg MC.
    Ann Med; 2011 Dec 29; 43(8):594-605. PubMed ID: 22017620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.